Nrx pharmaceuticals leaders to present at the h.c. wainwright & co. 1st annual mental health conference: neuropsychiatry, psychedelics, and beyond

Company to present corporate and psychiatry franchise update during webcast, june 27, 2022, at 7:00am et  radnor, pa. , june 23, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp), ("nrx pharmaceuticals"), a clinical-stage biopharmaceutical company, today announced its interim chief executive officer, robert besthof, and other executive leaders will be presenting a virtual update to the company's business via webcast at the h.c.
NRXP Ratings Summary
NRXP Quant Ranking